Correlation Between OnKure Therapeutics, and EvoAir Holdings

Can any of the company-specific risk be diversified away by investing in both OnKure Therapeutics, and EvoAir Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OnKure Therapeutics, and EvoAir Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OnKure Therapeutics, and EvoAir Holdings, you can compare the effects of market volatilities on OnKure Therapeutics, and EvoAir Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OnKure Therapeutics, with a short position of EvoAir Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of OnKure Therapeutics, and EvoAir Holdings.

Diversification Opportunities for OnKure Therapeutics, and EvoAir Holdings

0.0

Correlation Coefficient

OnKure Therapeutics,  EvoAir Holdings

Pay attention - limited upside

The 3 months correlation between OnKure and EvoAir is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OnKure Therapeutics, and EvoAir Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EvoAir Holdings and OnKure Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OnKure Therapeutics, are associated (or correlated) with EvoAir Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EvoAir Holdings has no effect on the direction of OnKure Therapeutics, i.e., OnKure Therapeutics, and EvoAir Holdings go up and down completely randomly.

Pair Corralation between OnKure Therapeutics, and EvoAir Holdings

Given the investment horizon of 90 days OnKure Therapeutics, is expected to generate 30.59 times more return on investment than EvoAir Holdings. However, OnKure Therapeutics, is 30.59 times more volatile than EvoAir Holdings. It trades about 0.01 of its potential returns per unit of risk. EvoAir Holdings is currently generating about 0.05 per unit of risk. If you would invest  2,600  in OnKure Therapeutics, on October 4, 2024 and sell it today you would lose (1,748) from holding OnKure Therapeutics, or give up 67.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.59%
Values	Daily Returns

OnKure Therapeutics,  vs.  EvoAir Holdings

OnKure Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OnKure Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

EvoAir Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days EvoAir Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, EvoAir Holdings is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with OnKure Therapeutics, and EvoAir Holdings

The main advantage of trading using opposite OnKure Therapeutics, and EvoAir Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OnKure Therapeutics, position performs unexpectedly, EvoAir Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EvoAir Holdings will offset losses from the drop in EvoAir Holdings' long position.

The idea behind OnKure Therapeutics, and EvoAir Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.